Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients

Cancer Letters

Volumn 252, Issue 1, 2007, Pages 131-146

  Nadin, Silvina Beatriz ^a   Vargas Roig, Laura M ^a   Drago, Gisela ^b   Ibarra, Jorge ^c   Ciocca, Daniel R ^a  

^a INSTITUTO ARGENTINO DE NIVOLOGÍA   (Argentina)

^b Hospital Pediatrico Dr Humberto Notti   (Argentina)

^c Oncologic Center of Regional Integration   (Argentina)

Author keywords

Cancer; Comet assay; Heat shock proteins; Lymphocytes; Mismatch repair

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; IFOSFAMIDE; PREDNISONE; PROCARBAZINE; PROTEIN MLH1; PROTEIN MSH2; VINBLASTINE; VINCRISTINE;

ADULT; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; COMET ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA DAMAGE; EWING SARCOMA; FEMALE; GRANULOSA CELL TUMOR; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; LARYNX CANCER; MALE; MALIGNANT NEURILEMOMA; MISMATCH REPAIR; MULTIPLE CYCLE TREATMENT; NEPHROBLASTOMA; OSTEOSARCOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CISPLATIN; CYTOPLASM; DNA; DNA DAMAGE; DNA MISMATCH REPAIR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INFANT; LYMPHOCYTES; MALE; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; PROGNOSIS;

EID: 34248400771     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.12.028     Document Type: Article

References (55)

1. Bignami M., Casorelli I., and Karran P. Mismatch repair and response to DNA damaging antitumor therapies. Eur. J. Cancer 39 (2003) 2142-2149
2. Hawn M.T., Umar A., Carethers J.M., Marra G., Kunkel T.A., Boland C.R., and Koi M. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res. 55 (1995) 3721-3725
3. Stojic L., Brun R., and Jiricny J. Mismatch repair and DNA damage signaling. DNA Repair 3 (2004) 1091-1101
4. Hsieh P. Molecular mechanisms of DNA mismatch repair. Mutat. Res. 486 (2001) 71-87
5. Genschel J., and Modrich P. Mechanism of 5′-directed excision in human mismatch repair. Mol. Cell 12 (2003) 1077-1086
6. Kolodner R.D., and Marsischky G.T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9 (1999) 89-96
7. Drummond J.T., Anthoney A., Brown R., and Modrich P. Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem. 271 (1996) 19645-19648
8. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehme A., Christen R.D., and Howell S.B. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 56 (1996) 4881-4886
9. Fedier A., Schwarz V.A., Walt H., Carpini R.D., Haller U., and Fink D. Resistance to topoisomerase poisons due to loss of DNA mismatch repair. Int. J. Cancer 93 (2001) 571-576
10. Fink D., Nebel S., Norris P.S., Baergen N.R., Wilczynski S.P., Costa M.J., Haas M., Cannistra S.A., and Howell S.B. Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin. Int. J. Cancer 77 (1998) 741-746
11. Brown R., Hirst G.L., Gallagher W.M., McIlwrath A.J., Margison G.P., van der Zee A.G., and Anthoney D.A. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. Oncogene 15 (1997) 45-52
12. Samimi G., Fink D., Varki N.M., Husain A., Hoskins W.J., Alberts D.S., and Howell S.B. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin. Cancer Res. 6 (2000) 1415-1421
13. Mackay H.J., Cameron D., Rahilly M., Mackean M.J., Paul J., Kaye S.B., and Brown R. Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival. J. Clin. Oncol. 18 (2000) 87-93
14. Muller I., Niethammer D., and Bruchelt G. Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). Int. J. Mol. Med. 1 (1998) 491-494
15. Skladanowski A., and Konopa J. Relevance of interstrand DNA crosslinking induced by anthracyclines for their biological activity. Biochem. Pharmacol. 47 (1994) 2279-2287
16. Jordan P., and Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell. Mol. Life Sci. 57 (2000) 1229-1235
17. Duckett D.R., Drummond J.T., Murchie A.I., Reardon J.T., Sancar A., Lilley D.M., and Modrich P. Human MutSα recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA 93 (1996) 6443-6447
18. Lindquist S. The heat shock response. Annu. Rev. Biochem. 55 (1986) 1151-1191
19. Parcellier A., Gurbuxani S., Schmitt E., Solary E., and Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem. Biophys. Res. Commun. 304 (2003) 505-512
20. Jäättelä M. Escaping cell death: survival proteins in cancer. Exp. Cell Res. 248 (1999) 30-43
21. Calderwood S.K., Khaleque M.A., Sawyer D.B., and Ciocca D.R. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem. Sci. 31 (2006) 164-172
22. Ciocca D.R., and Vargas-Roig L.M. Heat shock proteins and drug resistance in breast cancer. In: Bernal S.D. (Ed). Drug Resistance in Oncology (1997), Marcel Dekker Inc., New York 167-190
23. Ciocca D.R., Fuqua S.A., Lock-Lim S., Toft D.O., Welch W.J., and McGuire W.L. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res. 52 (1992) 3648-3654
24. Nadin S.B., Vargas-Roig L.M., Cuello-Carrión F.D., and Ciocca D.R. Deoxyribonucleic acid damage induced by doxorubicin in peripheral blood mononuclear cells: possible roles for the stress response and the deoxyribonucleic acid repair process. Cell Stress Chaperones 8 (2003) 361-372
25. Oshita F., Yamamoto N., Fukuda M., Ohe Y., Tamura T., Eguchi K., Shinkai T., and Saijo N. Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro. Cancer Res. 55 (1995) 2334-2337
26. Nadin S.B., Vargas-Roig L.M., Drago G., Ibarra J., and Ciocca D.R. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy. Cancer Lett. 239 (2006) 84-97
27. Damiani M.T., and Colombo M.I. Microfilaments and microtubules regulates recycling from phagosomes. Exp. Cell Res. 289 (2003) 152-161
28. Olive P.L., Wlodek D., Durand R.E., and Banath J.P. Factors influencing DNA migration from individual cells subject to gel electrophoresis. Exp. Cell. Res. 198 (1992) 259-267
29. Branham M.T., Nadin S.B., Vargas-Roig L.M., and Ciocca D.R. DNA damage induced by paclitaxel and DNA repair capability of peripheral blood lymphocytes as evaluated by the alkaline comet assay. Mutat. Res. 560 (2004) 11-17
30. Nadin S.B., Vargas-Roig L.M., and Ciocca D.R. A silver staining method for single-cell gel assay. J. Histochem. Cytochem. 49 (2001) 1183-1186
31. Anderson D., Yu T.-W., Phillips B.J., and Shemezer P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay. Mutat. Res. 307 (1994) 261-271
32. Matsumoto H., Hayashi S., Shioura H., Ohtsubo T., Ohnishi T., and Kano E. Suppression of heat-induced hsp72 accumulation by cisplatin in human glioblastoma cells. Cancer Lett. 110 (1996) 253-257
33. Matsumoto H., Hayashi S., Shioura H., Ohtsubo T., Kitai R., Ohnishi K., Hayashi N., Ohnishi T., and Kano E. Suppression of heat-induced HSF activation by CDDP in human glioblastoma cells. Int. J. Radiat. Oncol. Biol. Phys. 41 (1998) 915-920
34. Huber S.A. Heat-shock protein induction in adriamycin and picornavirus-infected cardiocytes. Lab. Invest. 67 (1992) 218-224
35. Omar R., and Pappolla M. Oxygen free radicals as inducers of heat shock protein synthesis in cultured human neuroblastoma cells: relevance to neurodegenerative disease. Eur. Arch. Psychiatry Clin. Neurosci. 242 (1993) 262-267
36. Leel Y.J., Galoforo S.S., Berns C.M., Chen J.C., Davis B.H., Sim J.E., Corry P.M., and Spitz D.R. Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J. Biol. Chem. 273 (1998) 5294-5299
37. Larson E.D., and Drummond J.T. Human mismatch repair and G-T mismatch binding by hMutSα in vitro is inhibited by adriamycin, actinomycin D, and nogalamycin. J. Biol. Chem. 276 (2001) 9775-9783
38. Fairbairn D.W., Olive P.L., and O'Neill K.L. The comet assay: a comprehensive review. Mutat. Res. 339 (1995) 37-59
39. Fichtinger-Schepman A.M.J., van der Velde-Visser S.D., van Dijk-Knijnenburg H.C.M., van Oosterom A.T., Baan R.A., and Berends F. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation. Cancer Res. 50 (1990) 7887-7894
40. Blasiak J., Kowalik J., Maleka-Panas E., Drzewoski J., and Wojewódzka M. DNA damage and repair in human lymphocytes exposed to three anticancer platinum drugs. Teratog. Carcinog. Mutagen. 20 (2000) 119-131
41. Reardon J.T., Vaisman A., Chaney S.G., and Sancar A. Efficient nucleotide excision repair of cisplatin, oxaliplatin, andbis-acetoammine-dichloro-cyclohexylamine-platinum (IV) (JM216) platinum intrastrand DNA diadducts. Cancer Res. 59 (1999) 3968-3971
42. Palyvoda O., Polansk J., Wygoda A., and Rzeszowska-Wolny J. DNA damage and repair in lymphocytes of normal individuals and cancer patients: studies by the comet assay and micronucleus tests. Acta Biochim. Pol. 50 (2003) 181-190
43. Colleu-Durel S., Guitton N., Nourgalieva K., Leveque J., Danic B., and Chenal C. Genomic instability and breast cancer. Oncol. Rep. 8 (2001) 1001-1005
44. Rajaee-Behbanahani N., Schmezer P., Risch A., Rittgen W., Kayse K.W., Dienemann H., Schulz V., Drings P., Thiel S., and Bartsch H. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int. J. Cancer (Pred. Oncol.) 95 (2001) 86-91
45. Johnstone E.C., Lind M.J., Griffin M.J., and Boddy A.V. Ifosfamide metabolism and DNA damage in tumor and peripheral blood lymphocytes of breast cancer patients. Cancer Chemother. Pharmacol. 46 (2000) 433-441
46. Blasiak J., Widera K., and Pertynski T. Hyperthermia can differentially modulate the repair of doxorubicin-damaged DNA in normal and cancer cells. Acta Biochim. Pol. 50 (2003) 191-195
47. Jansson A., Arbman G., Zhang H., and Sun X.-F. Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer. Int. J. Oncol. 22 (2003) 41-49
48. Salvesen H.B., MacDonald N., Ryan A., Iversen O.E., Jacobs I.J., Akslen L.A., and Das S. Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin. Cancer Res. 6 (2000) 3607-3613
49. Mendez F., Sandigursky M., Franklin W.A., Kenny M.K., Kureekattil R., and Bases R. Heat-shock proteins associated with base excision repair enzymes in HeLa cells. Radiat. Res. 2 (2000) 186-195
50. Mendez F., Kozin E., and Bases R. Heat shock protein 70 stimulation of the deoxyribonucleic acid base excision repair enzyme polymerase beta. Cell Stress Chaperones 8 (2003) 153-161
51. Wano C., Kita K., Takahashi S., Sugaya S., Hino M., Hosoya H., and Suzuki N. Protective role of Hsp27 against UVC-induced cell death in human cells. Exp. Cell Res. 298 (2004) 584-592
52. Hunt C.R., Dix D.J., Sharma G.G., Pandita R.K., Gupta A., Funk M., and Pandita T.K. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Mol. Cell. Biol. 24 (2004) 899-911
53. Vargas-Roig L.M., Gago F.E., Tello O., Aznar J.C., and Ciocca D.R. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int. J. Cancer (Pred. Oncol.) 79 (1998) 468-475
54. Arts H.J., Hollema H., Lemstra W., Willemse P.H., De Vries E.G., Kampinga H.H., and Van der Zee A.G. Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int. J. Cancer 84 (1999) 234-248
55. Romanet T., Re J.L., De Meo M., Serre-Debeauvlais F., Lavieille J.P., Reyt E., and Riva C. Detection of hypoxia by measurement of DNA damage and repair in human lymphocytes (comet assay): a predictive variable for tumor response during chemotherapy in patients with head and neck squamous cell carcinoma. In Vivo 13 (1999) 343-348